论文信息 - Burosumab versus continuation of conventional therapy in children with X-linked hypophosphatemia: a randomised, active-controlled, open-label, phase 3 trial - 字舞流文

Burosumab versus continuation of conventional therapy in children with X-linked hypophosphatemia: a randomised, active-controlled, open-label, phase 3 trial

Farzana | F. Glorieux | H. Cheong | E. Sochett | M. Whyte | J. Simmons | A. Biggin | N. Namba | K. Muroya | W. Högler | R. Padidela | Munns | A. Portale | G. Gottesman | E. Imel | M. Mao | A. Skrinar | Martin | J. San | Hiroyuki Tanaka | Chao‐Yin Chen | Pitukcheewanont | F. Craig | Prof Leanne Ward | Prof. Ola Nilsson | Pisit | Perwad | Hiroyuki Tanaka